| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6062857 | Journal of Allergy and Clinical Immunology | 2016 | 10 Pages |
Abstract
These data indicate a potential clinical use of Ca-SP containing Spirulina species extract for the prophylactic treatment of herpes labialis and suggest possible activity of Ca-SP against infections caused by other herpesviruses.
Keywords
IC50SPMECalcium spirulanHSVKSHV/HHV-8CHXPMUPRAACVTCID5050% tissue culture infective doseMOIPlaque reduction assayAcyclovirHerpes labialisKaposi sarcomacycloheximidehalf-maximal inhibitory concentrationplaque-forming unitsherpes simplex virusHerpes simplex virus 1pfumultiplicity of infectionKeratinocytes
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Julia MEd, Antonio PhD, Tim MSc, Wiebke PhD, Claus-Henning PhD, Patrick RPh, Wolfram MD, Kristian MD, PhD,